ATE338550T1 - Mikronisierter zolpidem hemitartrat - Google Patents

Mikronisierter zolpidem hemitartrat

Info

Publication number
ATE338550T1
ATE338550T1 AT04010651T AT04010651T ATE338550T1 AT E338550 T1 ATE338550 T1 AT E338550T1 AT 04010651 T AT04010651 T AT 04010651T AT 04010651 T AT04010651 T AT 04010651T AT E338550 T1 ATE338550 T1 AT E338550T1
Authority
AT
Austria
Prior art keywords
zolpidem hemitartrate
micronized
micronized zolpidem
hemitartrate
polymorphs
Prior art date
Application number
AT04010651T
Other languages
German (de)
English (en)
Inventor
Judith Aronhime
David Leonov
Erzebet Meszaros-Sos
Szaboles Salyi
Shlomo Zavurov
Csaba Szabo
Original Assignee
Teva Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27394001&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE338550(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Teva Pharma filed Critical Teva Pharma
Application granted granted Critical
Publication of ATE338550T1 publication Critical patent/ATE338550T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Amplifiers (AREA)
  • Supply Devices, Intensifiers, Converters, And Telemotors (AREA)
  • Suspension Of Electric Lines Or Cables (AREA)
  • Other Liquid Machine Or Engine Such As Wave Power Use (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT04010651T 2000-04-24 2001-04-24 Mikronisierter zolpidem hemitartrat ATE338550T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19929800P 2000-04-24 2000-04-24
US20602500P 2000-05-22 2000-05-22
US22536400P 2000-08-14 2000-08-14

Publications (1)

Publication Number Publication Date
ATE338550T1 true ATE338550T1 (de) 2006-09-15

Family

ID=27394001

Family Applications (4)

Application Number Title Priority Date Filing Date
AT04010651T ATE338550T1 (de) 2000-04-24 2001-04-24 Mikronisierter zolpidem hemitartrat
AT01930705T ATE308324T1 (de) 2000-04-24 2001-04-24 Zolpidem hemitartrat
AT04010435T ATE335481T1 (de) 2000-04-24 2001-04-24 Zolpidem hemitartrat solvat
AT05001922T ATE348613T1 (de) 2000-04-24 2001-04-24 Zolpidem hemitartrat solvat

Family Applications After (3)

Application Number Title Priority Date Filing Date
AT01930705T ATE308324T1 (de) 2000-04-24 2001-04-24 Zolpidem hemitartrat
AT04010435T ATE335481T1 (de) 2000-04-24 2001-04-24 Zolpidem hemitartrat solvat
AT05001922T ATE348613T1 (de) 2000-04-24 2001-04-24 Zolpidem hemitartrat solvat

Country Status (21)

Country Link
US (8) US20020077332A1 (enExample)
EP (1) EP1292304B1 (enExample)
JP (3) JP2003531173A (enExample)
KR (1) KR20030069796A (enExample)
AT (4) ATE338550T1 (enExample)
AU (2) AU2001257213B2 (enExample)
CA (1) CA2406982A1 (enExample)
CZ (1) CZ20023775A3 (enExample)
DE (7) DE60114617T2 (enExample)
DK (1) DK1292304T3 (enExample)
ES (4) ES2239558T3 (enExample)
HR (1) HRP20020909A2 (enExample)
HU (1) HUP0300701A2 (enExample)
IL (1) IL152411A0 (enExample)
NZ (1) NZ522015A (enExample)
PL (1) PL358548A1 (enExample)
PT (3) PT1473036E (enExample)
SE (1) SE5292304T3 (enExample)
SK (1) SK16372002A3 (enExample)
WO (1) WO2001080857A1 (enExample)
YU (1) YU79402A (enExample)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6921839B2 (en) 2000-08-29 2005-07-26 Ranbaxy Laboratories Limited Synthesis of N,N-dimethyl-3-(4-methyl) benzoyl propionamide a key intermediate of zolpidem
US6869970B2 (en) 2002-02-04 2005-03-22 Novartis Ag Crystalline salt forms of valsartan
EP1575952B1 (en) 2002-12-18 2009-02-18 Mallinckrodt Inc. Synthesis of heteroaryl acetamides
WO2004087703A1 (en) * 2003-03-12 2004-10-14 Sun Pharmaceutical Industries Limited Process for the preparation of n,n,6-trimethyl-2-(4-methylphenyl)-imidazo[1,2-a]pyridine-3-acetamide
WO2005010002A1 (en) * 2003-07-31 2005-02-03 Ranbaxy Laboratories Limited Process for the synthesis of zolpidem
KR20070030178A (ko) * 2004-02-17 2007-03-15 트랜스오랄 파마슈티칼스, 인코포레이티드 구강 점막을 가로지르는 수면제 전달용 조성물 및 이의사용 방법
WO2006008636A2 (en) * 2004-07-16 2006-01-26 Ranbaxy Laboratories Limited Processes for the preparation of zolpidem and its hemitartrate
US20070123562A1 (en) * 2005-05-25 2007-05-31 Transoral Pharmaceuticals, Inc. Compositions and methods for treating middle-of-the-night insomnia
US20070287740A1 (en) * 2005-05-25 2007-12-13 Transcept Pharmaceuticals, Inc. Compositions and methods of treating middle-of-the night insomnia
US20070225322A1 (en) * 2005-05-25 2007-09-27 Transoral Pharmaceuticals, Inc. Compositions and methods for treating middle-of-the night insomnia
AU2006283702A1 (en) * 2005-08-19 2007-03-01 Aventis Pharmaceuticals Inc. Comination of a hypnotic agent and R(+)-alpha-(2,3-dimethoxy-phenyl)-1-(2-(4-fluorophenl)ethyl)-4-piperidinemethanol and therapeutic application thereof
BRPI0614943A2 (pt) * 2005-08-19 2011-04-26 Aventis Pharma Inc combinação de um agente hipnótico e composto de bisarila e heteroarila substituìdo e aplicação terapêutica da mesma
CA2624340A1 (en) * 2005-10-03 2007-04-12 Mallinckrodt Inc. Process for preparing zolpidem hemitartrate and tartrate polymorphs
CA2626242A1 (en) * 2005-10-17 2007-04-26 Mallinckrodt Inc. Polymorph transformation of zolpidem in tablet matrix
US20070098788A1 (en) * 2005-10-28 2007-05-03 Gore Subhash P Non-benzodiazepine hypnotic compositions
MX2008012655A (es) 2006-03-31 2008-12-16 Janssen Pharmaceutica Nv Benzoimidazol-2-il-pirimidinas y -pirazinas como moduladores de receptor de histamina h4.
WO2008067549A2 (en) * 2006-11-30 2008-06-05 Transcept Pharmaceuticals, Inc. Stabilized zolpidem pharmaceutical compositions
US20080145425A1 (en) * 2006-12-15 2008-06-19 Pliva Research & Development Limited Pharmaceutical composition of zolpidem
US9371311B2 (en) 2008-06-30 2016-06-21 Janssen Pharmaceutica Nv Benzoimidazol-2-yl pyrimidine derivatives
SG192446A1 (en) * 2008-06-30 2013-08-30 Janssen Pharmaceutica Nv Process for the preparation of benzoimidazol-2-yl pyrimidine derivatives
MY160542A (en) 2009-11-27 2017-03-15 Genzyme Corp An amorphous and a crystalline form of genz 112638 hemitartrate as inhibitor of glucosylceramide synthase
WO2011115069A1 (ja) * 2010-03-19 2011-09-22 第一三共株式会社 結晶の網羅的探索
HUE047681T2 (hu) * 2013-03-06 2020-05-28 Janssen Pharmaceutica Nv A hisztamin H4 receptor benzimidazol-2-il-pirimidin modulátorai
CN116283957A (zh) * 2021-12-03 2023-06-23 山东新时代药业有限公司 唑吡坦水合物及其制备方法
CN116283958A (zh) * 2021-12-03 2023-06-23 山东新时代药业有限公司 唑吡坦共晶体及其制备方法
CN117907368A (zh) * 2024-01-27 2024-04-19 鲁南贝特制药有限公司 一种酒石酸唑吡坦药用晶型d中晶型a、e的定量测定方法
CN118750459B (zh) * 2024-07-22 2025-04-01 常州市武进中医医院 一种酒石酸唑吡坦片及其制备方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4151273A (en) * 1974-10-31 1979-04-24 The Regents Of The University Of California Increasing the absorption rate of insoluble drugs
FR2408345A1 (fr) * 1976-11-30 1979-06-08 Besins Jean Louis Nouvelle composition a action anti-conceptionnelle
US4302446A (en) * 1979-10-02 1981-11-24 Bristol-Myers Company Pharmaceutical compositions
IT1130924B (it) * 1980-03-06 1986-06-18 Secifarma Spa Procedimento per la preparazione di spironolattone micronizzato
DE3018940A1 (de) * 1980-05-17 1981-11-26 Hoechst Ag, 6000 Frankfurt Verwendung eines vinylchlorid-pfropf-copolymerisates in der plastisolverarbeitung
FR2492382A1 (fr) * 1980-10-22 1982-04-23 Synthelabo Derives d'imidazo (1,2-a) pyridine, leur preparation et leur application en therapeutique
FR2525601A1 (fr) * 1982-04-21 1983-10-28 Synthelabo Derives d'imidazo(1,2-a)pyridines, leur preparation et leur application en therapeutique
US4675323A (en) * 1985-08-06 1987-06-23 Synthelabo Imidazo(1,2-a)quinoline derivatives useful as anxiolytic agents
SE457326B (sv) * 1986-02-14 1988-12-19 Lejus Medical Ab Foerfarande foer framstaellning av en snabbt soenderfallande kaerna innehaallande bl a mikrokristallin cellulosa
FR2600650B1 (fr) * 1986-06-27 1988-09-09 Synthelabo Procede de preparation d'imidazopyridines et composes intermediaires
FR2606410B1 (fr) * 1986-11-07 1989-02-24 Synthelabo Imidazopyridines, leur preparation et leur application en therapeutique
DE3865073D1 (de) * 1987-03-27 1991-10-31 Synthelabo Imidazopyridinderivate, ihre herstellung und therapeutische verwendung.
US5271944A (en) * 1991-04-05 1993-12-21 Biofor, Ltd. Pharmacologically enhanced formulations
IT1276522B1 (it) * 1995-04-07 1997-10-31 Elena Benincasa Uso dello zolpidem per il trattamento terapeudico di sindromi neuropsichiatriche associate a disfunsione e di circuiti neurali dei
SI1038875T1 (en) * 1999-03-25 2003-12-31 Synthon B.V. Imidazopyridine derivatives and process for making them
AU3464200A (en) * 1999-03-25 2000-10-16 Synthon B.V. Zolpidem salts
WO2001042239A1 (en) * 1999-12-13 2001-06-14 Sumika Fine Chemicals Co., Ltd. Process for the preparation of a pyridinemethanol compound

Also Published As

Publication number Publication date
US20040220212A1 (en) 2004-11-04
DE60114617T2 (de) 2006-07-27
DE60122216T2 (de) 2007-08-30
HRP20020909A2 (en) 2004-08-31
AU5721301A (en) 2001-11-07
DE60125429D1 (de) 2007-02-01
US20040214859A1 (en) 2004-10-28
WO2001080857A1 (en) 2001-11-01
DE60125429T2 (de) 2007-09-27
CA2406982A1 (en) 2001-11-01
JP2006137778A (ja) 2006-06-01
DE20122435U1 (de) 2005-10-06
ES2239558T3 (es) 2007-04-01
DE60122944T2 (de) 2007-04-12
EP1292304A1 (en) 2003-03-19
DK1292304T3 (da) 2005-12-19
ES2248321T3 (es) 2006-03-16
US20040220211A1 (en) 2004-11-04
US20040214858A1 (en) 2004-10-28
SE5292304T3 (enExample) 2005-11-02
US20040220210A1 (en) 2004-11-04
YU79402A (sh) 2006-03-03
DE04010435T1 (de) 2005-09-01
EP1292304A4 (en) 2003-07-23
PT1475093E (pt) 2006-11-30
DE60122216D1 (de) 2006-09-21
ATE308324T1 (de) 2005-11-15
EP1292304B1 (en) 2005-11-02
DE04010651T1 (de) 2005-09-01
US20020077332A1 (en) 2002-06-20
DE60122944D1 (de) 2006-10-19
ES2277301T3 (es) 2007-07-01
PT1473036E (pt) 2006-10-31
ES2239558T1 (es) 2005-10-01
PT1541146E (pt) 2007-01-31
WO2001080857A9 (en) 2002-06-27
KR20030069796A (ko) 2003-08-27
US20040220213A1 (en) 2004-11-04
US20070037843A1 (en) 2007-02-15
DE60114617D1 (de) 2005-12-08
ES2238941T3 (es) 2007-04-01
ATE348613T1 (de) 2007-01-15
IL152411A0 (en) 2003-05-29
HUP0300701A2 (hu) 2003-07-28
PL358548A1 (en) 2004-08-09
ES2238941T1 (es) 2005-09-16
JP2003531173A (ja) 2003-10-21
AU2001257213B2 (en) 2005-09-29
CZ20023775A3 (cs) 2003-10-15
ATE335481T1 (de) 2006-09-15
JP2006249105A (ja) 2006-09-21
SK16372002A3 (sk) 2003-04-01
NZ522015A (en) 2004-08-27

Similar Documents

Publication Publication Date Title
ATE338550T1 (de) Mikronisierter zolpidem hemitartrat
DK1543002T3 (da) Fremstilling af 1H-imidazo (4,5-c) quinolin-4-aminer via 1H-imidazo (4,5-c) quinolin-4-phtalimid mellemprodukter
ATE420879T1 (de) Indolizine als kinaseproteinhemmer
ATE302775T1 (de) Carbolinderivate
SE0101675D0 (sv) Novel composition
DK1242382T3 (da) Tricycliske proteinkinaseinhibitorer
TR200103574T2 (tr) Amid ikameli/katkılı imidazokinolinler
DK1206474T3 (da) Sulfonylphenylpyrazolforbindelser anvendelige som cox-2-inhibitorer
ATE346067T1 (de) Carbolinderivate
DK1456212T3 (da) 6-aminomorphinanderivater, fremgangsmåder til fremstilling heraf og disses anvendelse
IL153680A0 (en) Aplidine derivatives and methods for the preparation thereof
ATE297931T1 (de) Tricyclische imidazopyridine
NO20052794L (no) Antibakterielle indolonoksazolidinoner intermediater for fremstilling av disse og farmasoytiske prepareter inneholdende disse
SE0102716D0 (sv) Novel compounds
DK1198225T3 (da) Epothilonsammensætninger
ATE274515T1 (de) Pyrazolopyridinderivate
ITMI20001695A0 (it) Procedimento per la preparazione di composizioni organico-sili-coniche.
IS8034A (is) Imídasó[4,5-B]kínólínafleiður og notkun þeirra sem NO-myndunarhemla
NO20053829D0 (no) Fremgangsmate og intermediater for fremstilling av olanzapin.
ITPN20020071A1 (it) Procedimento per la fabbricazione di mobili.
CY1115144T1 (el) Παραγωγα του uk-2a
ITMI20001600A0 (it) Procedimento per la preparazione di 5-amino-4-alo-3-alchil isossazoli.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties